Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

CertaDose Wins Johnson & Johnson Innovation Award for Advancing Safety in Healthcare

Posted on: 12 Dec 17

One of the most common mistakes made in emergency rooms is giving children the wrong dose of medicine. Emerging medical device start-up CertaDoseTM, Inc. was recognized by Johnson & Johnson Innovation LLC as having a potential solution for this problem and named the winner of its QuickFire Challenge: Advancing the Safe Use of Healthcare Products.

CertaDose was selected out of nearly 100 applicants from across the world, based on its potential to significantly reduce pediatric medication dosing errors and affect change in the practice of emergency medicine with its color-coded pediatric dosing system. The honor was presented to CertaDose founder and Chief Medical Officer Dr. Caleb Hernandez on Tuesday, November 28 in New York.

“Hundreds of thousands of children are injured and roughly 7,000 kids die each year from medical dosing errors. The healthcare industry recognizes that we have a problem, and we need a truly effective solution,” commented Dr. Hernandez. “The CertaDose system offers a simple, intuitive way to quickly and accurately administer medications to kids in need, and studies show our system reduces critical dosing errors. We are honored to have Johnson & Johnson Innovation recognize our company’s potential, and we look forward to making pediatric dosing errors a thing of the past.”

As part of the recognition, CertaDose will receive a research grant, entrance to a Johnson & Johnson Innovation, JLABS site and mentoring from experts at Johnson & Johnson Office of the Chief Medical Officer.

Founded by Dr. Caleb Hernandez in Denver, Colorado, CertaDose is an early-stage medical device company headquartered in San Antonio, Texas. CertaDose’s first product is an U.S. Food and Drug Administration-cleared syringe for use with the administration of epinephrine to pediatric patients. Each syringe is labeled with easy to recognize color zones that match the industry standard Broselow® color system to help clinicians verify the correct dose during critical, time-sensitive situations. Users match the patient to a zone on the color scale, and administer the medication to the corresponding color on the CertaDose syringe. The patented syringe incorporates the right dose, the right concentration and the right route of administration of medication dosing, along with a color-matching technology that creates an easy-to-use system, focused on saving children’s lives by curbing critical medication errors.

View source version on

Business Wire

Last updated on: 12/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.